About usHistoryCulture
EHS SystemQuality System
APICDMO
Work PhilosophyRecruitment News
To be the Reliable Supplier in the Global Pharmaceutical Supply Chain
Home > Business > API
API CDMO
Cas No.：1072833-77-2
Ixazomib (MLN2238) is a selective, potent, and reversible proteasome inhibitor, which inhibits the chymotrypsin-like proteolytic (β5) site of the 20S proteasome with an IC50 of 3.4 nM (Ki of 0.93 nM).
E-mail Product Inquiry
Title：
Cas No.：
Name：
Telephone：
E-mail：
Message：
Submit
